CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
- Product NDC
- 50742-256
- 11-digit product format
- 507420256
- Labeler code
- 50742
- Product ID
- 50742-256_2830de59-4682-421c-b51a-c2492d153d67
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carisoprodol, aspirin and codeine phosphate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA040860
- Marketing category
- ANDA
- Marketing start
- 2019-01-21
- Marketing end
- 2022-07-31
- Substance
- CARISOPRODOL; ASPIRIN; CODEINE PHOSPHATE
- Active strength
- 200 mg/1; mg/1; mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-256-01 | 50742025601 | 100 TABLET in 1 BOTTLE, PLASTIC (50742-256-01) | 100 tablet | 2019-01-21 | 0000-00-00 | No | No | Current |